drugset / Trial / NCT04646876
Mgso4 as Neuroprotective in Post Traumatic Brain Injury
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this study is to assess the potential role of magnesium sulphate (MgSo4) as a neuroprotective agent using the Glasgow outcome scale following moderate and severe traumatic brain injury.
Timeline
- Start
- 2019-05-02
- Primary completion
- 2020-03-12
- Completion
- 2020-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Magnesium Sulfate | Other / unclassified | 25 mg/kg | Intravenous |